Diffusion of Innovations model helps interpret the comparative uptake of two methodological innovations: co-authorship network analysis and recommendations for the integration of novel methods in practice

Journal of Clinical Epidemiology

Volumn 84, Issue , 2017, Pages 150-160

  Cadarette, Suzanne M ^a   Ban, Joann K ^a   Consiglio, Giulia P ^a   Black, Cody D ^a   Dubins, David ^a   Marin, Alexandra ^a   Tadrous, Mina ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bibliometrics; Diffusion of innovation; Disease risk score; Methodological innovation; Pharmacoepidemiology; Propensity score; Social networks

Indexed keywords

ARTICLE; COMPARATIVE STUDY; HUMAN; INFORMATION; INTEGRATION; MASS COMMUNICATION; METHODOLOGY; NORTH AMERICA; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; PROPENSITY SCORE; RISK; SOCIETY; WRITING; BIBLIOMETRICS; PUBLISHING; STATISTICS AND NUMERICAL DATA;

AUTHORSHIP; BIBLIOMETRICS; DIFFUSION OF INNOVATION; HUMANS; PROPENSITY SCORE; PUBLISHING;

EID: 85011418935     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2016.12.006     Document Type: Article

References (31)

1. Hartzema, A.G., Tilson, H.H., Chan, K.A., Pharmacoepidemiology and therapeutic risk management. 2008, Harvey Whitney Books, Cincinnati.
2. Strom, B.L., Kimmel, S.E., Hennessy, S., Pharmacoepidemiology. 2011, Wiley-Blackwell, West Sussex.
3. Consiglio, G.P., Burden, A.M., Maclure, M., McCarthy, L., Cadarette, S.M., Case-crossover study design in pharmacoepidemiology: systematic review and recommendations. Pharmacoepidemiol Drug Saf 22 (2013), 1146–1153.
4. Jandoc, R., Burden, A.M., Mamdani, M., Lévesque, L.E., Cadarette, S.M., Interrupted time series analysis in drug utilization research is increasing: systematic review and recommendations. J Clin Epidemiol 68 (2015), 950–956.
5. Stürmer, T., Joshi, M., Glynn, R.J., Avorn, J., Rothman, K.J., Schneeweiss, S., A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol 59 (2006), 437–447.
6. Tadrous, M., Gagne, J.J., Stürmer, T., Cadarette, S.M., Disease risk score as a confounder summary method: systematic review and recommendations. Pharmacoepidemiol Drug Saf 22 (2013), 122–129.
7. Schneeweiss, S., Developments in post-marketing comparative effectiveness research. Clin Pharmacol Ther 82 (2007), 143–156.
8. Schneeweiss, S., Avorn, J., A review of uses of health care utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58 (2005), 323–337.
9. Suissa, S., Henry, D., Caetano, P., Dormuth, C.R., Ernst, P., Hemmelgarn, B., et al. CNODES: the Canadian Network for Observational Drug Effect Studies. Open Med 6 (2012), e134–e140.
10. Selby, J.V., Beal, A.C., Frank, L., The patient-centered outcomes research institute (PCORI) national priorities for research and initial research agenda. JAMA 307 (2012), 1583–1584.
11. Pullenayegum, E.M., Platt, R.W., Barwick, M., Feldman, B.M., Offringa, M., Thabane, L., Knowledge translation in biostatistics: a survey of current practices, preferences, and barriers to the dissemination and uptake of new statistical methods. Stat Med 35 (2016), 805–818.
12. Altman, D.G., Goodman, S.N., Transfer of technology from statistical journals to the biomedical literature. Past trends and future predictions. JAMA 272 (1994), 129–132.
13. Miettinen, O.S., Stratification by a multivariate confounder score. Am J Epidemiol 104 (1976), 609–620.
14. Schneeweiss, S., Rassen, J.A., Glynn, R.J., Avorn, J., Mogun, H., Brookhart, M.A., High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology 20 (2009), 512–522.
15. Rogers, E.M., Diffusion of innovations. 2003, Free Press, Toronto.
16. Stake, R.E., Qualitative case studies. 3rd ed, 2005, SAGE Publications, Thousand Oaks, CA.
17. Yin, R.K., Applications of case study research. 2nd ed, 2003, SAGE Publications, Thousand Oaks, CA.
18. Haider, M., Kreps, G.L., Forty years of diffusion of innovations: utility and value in public health. J Health Commun 9:Suppl 1 (2004), 3–11.
19. Cadarette, S.M., Gagne, J.J., Solomon, D.H., Katz, J.N., Stürmer, T., Confounder summary scores when comparing the effects of multiple drug exposures. Pharmacoepidemiol Drug Saf 19 (2010), 2–9.
20. Arbogast, P.G., Ray, W.A., Performance of disease risk scores, propensity scores, and traditional multivariable outcome regression in the presence of multiple confounders. Am J Epidemiol 174 (2011), 613–620.
21. Glynn, R.J., Gagne, J.J., Schneeweiss, S., Role of disease risk scores in comparative effectiveness research with emerging therapies. Pharmacoepidemiol Drug Saf 21 (2012), 138–147.
22. Pike, M.C., Anderson, J., Day, N., Some insights into Miettinen's multivariate confounder score approach to case-control study analysis. J Epidemiol Community Health 33 (1979), 104–106.
23. Cook, E.F., Goldman, L., Performance of tests of significance based on stratification by a multivariate confounder score or by a propensity score. J Clin Epidemiol 42 (1989), 317–324.
24. Stürmer, T., Schneeweiss, S., Brookhart, M.A., Rothman, K.J., Avorn, J., Glynn, R.J., Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol 161 (2005), 891–898.
25. Wyss, R., Lunt, M., Brookhart, M.A., Glynn, R.J., Stürmer, T., Reducing bias amplification in the presence of unmeasured confounding through out-of-sample estimation strategies for the disease risk score. J Causal Inference 2 (2014), 131–146.
26. Arbogast, P.G., Kaltenbach, L., Ding, H., Ray, W.A., Adjustment for multiple cardiovascular risk factors using a summary risk score. Epidemiology 19 (2008), 30–37.
27. Saito, R., Smoot, M.E., Ono, K., Ruscheinski, J., Wang, P.L., Lotia, S., et al. A travel guide to Cytoscape plugins. Nat Methods 9 (2012), 1069–1076.
28. Jick, H., Miettinen, O.S., Neff, R.K., Shapiro, S., Heinonen, O.P., Slone, D., Coffee and myocardial infarction. N Engl J Med 289 (1973), 63–67.
29. Rothman, K.J., Monson, R.R., Epidemiology of trigeminal neuralgia. J Chronic Dis 26 (1973), 3–12.
30. Miettinen, O., Neff, R.K., Computer processing of epidemiologic data. Hart Bull 2 (1971), 98–103.
31. Tscharntke, T., Hochberg, M.E., Rand, T.A., Resh, V.H., Krauss, J., Author sequence and credit for contributions in multiauthored publications. Plos Biol, 5, 2007, e18.